orlistat poudre | Lipid-Lowering Drugs CAS 96829-58-2

» Pharmaceutique » Poudre Fat Loss » Orlistat Powder | Lipid-Lowering Drugs CAS 96829-58-2

orlistat poudre | Lipid-Lowering Drugs CAS 96829-58-2

Poudre Fat Loss , , , , , , , , , , ,

NO CAS:96829-58-2
Formule moléculaire: C29H53NO5
Poids moléculaire: 495.7348
Essai: 99.6%
Boiling point: 615.9° C à 760 mmHg
Flash point: 326.3° C
Apparence: Au loin la poudre blanche

  • Caractéristiques

Buy Lipid-Lowering Drugs Orlistat Powder CAS 96829-58-2 for Fat loss


Orlistat Description

Orlistat (also known as tetrahydrolipstatin) is a drug designed to treat obesity.


Orlistat Powder Certificate Of Analysis

TESTS Specificatione Résultats
Description White or almost crystalline powder poudre cristalline blanche
Identification ET Conformes
Rotation spécifique -33 -35° -34°
Perte sur le séchage <0.5% 0.35%
Point de fusion 42-45ºC 42-44ºC
Water <=2.0% 0.25%
Solvants résiduels n-hexane<=290ppm
Essai(HPLC) >=96.0%(ON DRY BASIS) 99.6%


Orlistat Medical uses:

Orlistat is used for the treatment of obesity. The amount of weight loss achieved with orlistat varies. In one-year clinical trials, between 35.5% et 54.8% of subjects achieved a 5% or greater decrease in body mass, although not all of this mass was necessarily fat. Between 16.4% et 24.8% achieved at least a 10% decrease in body fat.After orlistat was stopped, a significant number of subjects regained weight-up to 35% of the weight they had lost.

The incidence of type 2 diabetes in an obese population over four years is decreased with orlistat (6.2%) compared to placebo (9.0%).Long-term use of orlistat also leads to a modest reduction in blood pressure (mean reductions of 2.5 et 1.9 mmHg in systolic and diastolic blood pressure respectively).

formulaire ( nous reviendrons dès que possible )


3 + 7 = ?

Peut-être que vous aimez aussi

  • catégories de produits

  • Messages récents

  • Partager